TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Miltenyi Biotec Norden AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
150,846
|
129,619
|
104,764 |
Financial expenses |
1
|
20
|
1 |
Earnings before taxes |
10,920
|
12,241
|
8,633 |
EBITDA |
13,128
|
13,532
|
9,445 |
Total assets |
62,593
|
53,181
|
53,843 |
Current assets |
54,534
|
45,458
|
51,263 |
Current liabilities |
43,028
|
42,147
|
32,398 |
Equity capital |
19,565
|
11,034
|
21,445 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
22
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
31.3%
|
20.7%
|
39.8% |
Turnover per employee |
6,857
|
6,822
|
5,820 |
Profit as a percentage of turnover |
7.2%
|
9.4%
|
8.2% |
Return on assets (ROA) |
17.4%
|
23.1%
|
16.0% |
Current ratio |
126.7%
|
107.9%
|
158.2% |
Return on equity (ROE) |
55.8%
|
110.9%
|
40.3% |
Change turnover |
21,227
|
24,855
|
10,216 |
Change turnover % |
16%
|
24%
|
11% |
Chg. No. of employees |
3
|
1
|
3 |
Chg. No. of employees % |
16%
|
6%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.